Drug Candidate
NLY02
Summary
Orally active, microglia-targeted small molecules for Neurodegenerative Disease
Mechanism of Action
Undisclosed
Indication
Parkinson’s & Alzheimer’s Disease
Development Stage
IND-Enabling
NLY02
NLY02
Orally active, microglia-targeted small molecules for Neurodegenerative Disease
Undisclosed
Parkinson’s & Alzheimer’s Disease
IND-Enabling